Autolus Therapeutics to Participate in Upcoming Investor Conferences

Core Insights - Autolus Therapeutics plc is a commercial-stage biopharmaceutical company focused on developing next-generation programmed T cell therapies for cancer and autoimmune diseases [3] Group 1: Upcoming Events - The company will participate in the Jefferies Biotech on the Beach Summit on March 11, 2025, in Miami, FL, hosting investor meetings [2] - Autolus will also present a fireside chat at the Leerink Global Biopharma Conference on March 12, 2025, at 8:40 am EDT / 12:40 pm GMT, led by CEO Dr. Christian Itin [2] - A webcast of the fireside chat will be available on the company's website, with a replay archived for 90 days [2] Group 2: Company Overview - Autolus utilizes proprietary and modular T cell programming technologies to create targeted and controlled T cell therapies [3] - The company has an FDA-approved product, AUCATZYL, and is developing a pipeline for treating hematological malignancies, solid tumors, and autoimmune diseases [3]